{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-059115","form_type":"8-K","ticker":"NKTR","cik":"0000906709","company_name":"NEKTAR THERAPEUTICS","filed_at":"2025-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.753428+00:00","generated_at":"2026-05-18T17:13:59.246410+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nektar Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq deficiency notice on April 3, 2025 for bid price below $1.00.","Regained compliance on June 23, 2025 after 10 consecutive trading days above $1.00.","Nasdaq confirmed compliance in a letter dated June 24, 2025.","Company continues to trade on The Nasdaq Capital Market under symbol NKTR."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-059115","json":"https://secwatch.observer/filing/0001213900-25-059115.json","markdown":"https://secwatch.observer/filing/0001213900-25-059115.md","text":"https://secwatch.observer/filing/0001213900-25-059115.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/906709/000121390025059115/0001213900-25-059115-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/906709/000121390025059115/ea0247333-8k_nektar.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T17:13:59.246410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}